The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development
Open accessAbstract
Background: Previous studies have reported conflicting results concerning the influence of age and gender on the pharmacokinetics and pharmacodynamics of fentanyl, alfentanil, and sufentanil. The aim of this study was to determine the influence of age and gender on the pharmacokinetics and pharmacodynamics of the new short-acting opioid remifentanil. Methods: Sixty-five healthy adults (38 men and 27 women) ages 20 to 85 y received remifentanil by constant-rate infusion of 1 to 8 micrograms.kg-1.min-1 for 4 to 20 min. Frequent arterial blood samples were drawn and assayed for remifentanil concentration. The electroencephalogram was used as a measure of drug effect. Population pharmacokinetic and pharmacodynamic modeling was performed using the software package NONMEM. The influence of volunteer covariates were analyzed using a generalized additive model. The performances of the simple (without covariates) and complex (with covariates) models were evaluated prospectively in an additional 15 healthy participants ages 41 to 84 y. Results: The parameters for the simple three-compartment pharmacokinetic model were V1 = 4.98 l, V2 = 9.01 l, V3 = 6.54 l, Cl1 = 2.46 l/min, Cl2 = 1.69 l/min, and Cl3 = 0.065 l/min. Age and lean body mass were significant covariates. From the ages of 20 to 85 y, V1 and Cl1 decreased by approximately 25% and 33%, respectively. The parameters for the simple sigmoid Emax pharmacodynamic model were Ke0 = 0.516 min-1, E0 = 20 Hz, Emax = 5.62 Hz, EC50 = 11.2 ng/ml, and gamma = 2.51. Age was a significant covariate of EC50 and Ke0, with both decreasing by approximately 50% for the age range studied. The complex pharmacokinetic-pharmacodynamic model performed better than did the simple model when applied prospectively. Conclusions: This study identified (1) an effect of age on the pharmacokinetics and pharmacodynamics of remifentanil; (2) an effect of lean body mass on the pharmacokinetic parameters; and (3) no influence of gender on any pharmacokinetic or pharmacodynamic parameter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Du BOIS, D. (1916) · Archives of Internal Medicine · doi:10.1001/archinte.1916.00080130010002 · Cited by 4,342
Pharmacokinetics and Pharmacodynamics of Remifentanil: II. Model Application
Minto, C. F., Schnider, T. W., & Shafer, S. L. (1997) · Anesthesiology · doi:10.1097/00000542-199701000-00005 · Cited by 682
Self-citationPharmacokinetics, Pharmacodynamics, and Rational Opioid Selection
Shafer, S. L., & Varvel, J. R. (1991) · Anesthesiology · doi:10.1097/00000542-199101000-00010 · Cited by 587
Self-citationBuilding population pharmacokineticpharmacodynamic models. I. Models for covariate effects
Mandema, J. W., Verotta, D., & Sheiner, L. B. (1992) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061469 · Cited by 500
Self-citationForecasting individual pharmacokinetics
Sheiner, L. B., Beal, S. L., Rosenberg, B., et al. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979263294 · Cited by 446
Westmoreland, C. L., Hoke, J. F., Sebel, P. S., Hug, C. C., & Muir, K. T. (1993) · Anesthesiology · doi:10.1097/00000542-199311000-00005 · Cited by 444
Self-citationSCOTT, J. C., & STANSKI, D. R. (1987) · Survey of Anesthesiology · doi:10.1097/00132586-198710000-00044 · Cited by 419
Egan, T. D., Minto, C. F., Hermann, D. J., Barr, J., Muir, K. T., & Shafer, S. L. (1996) · Anesthesiology · doi:10.1097/00000542-199604000-00009 · Cited by 409
Self-citationThe Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches
Kataria, B. K., Ved, S. A., Nicodemus, H. F., Hoy, G. R., Lea, D., Dubois, M. Y., Mandema, J. W., & Shafer, S. L. (1994) · Anesthesiology · doi:10.1097/00000542-199401000-00018 · Cited by 322
Self-citationScott, J. C., Cooke, J. E., & Stanski, D. R. (1991) · Anesthesiology · doi:10.1097/00000542-199101000-00007 · Cited by 322
Cited by
An fMRI-Based Neurologic Signature of Physical Pain
Wager, T. D., Atlas, L. Y., Lindquist, M. A., Roy, M., Woo, C.-W., & Kross, E. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1204471 · Cited by 1,597
Schnider, T. W., Minto, C. F., Gambus, P. L., Andresen, C., Goodale, D. B., Shafer, S. L., & Youngs, E. J. (1998) · Anesthesiology · doi:10.1097/00000542-199805000-00006 · Cited by 1,162
Self-citationBingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., & Tracey, I. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001244 · Cited by 810
Pharmacokinetic models for propofol—defining and illuminating the devil in the detail
Absalom, A. R., Mani, V., De Smet, T., & Struys, M. M. R. F. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep143 · Cited by 435
Population Pharmacokinetics of Propofol: A Multicenter Study
Schüttler, J., & Ihmsen, H. (2000) · Anesthesiology · doi:10.1097/00000542-200003000-00017 · Cited by 434
Metadata
- Authors
- Minto, C. F., Schnider, T. W., Egan, T. D., Youngs, E., Lemmens, H. J. M., Gambus, P. L., Billard, V., Hoke, J. F., Moore, K. H. P., Hermann, D. J., Muir, K. T., Mandema, J. W., & Shafer, S. L.
- Venue
- Anesthesiology
- Published
- 1997-01-01
- Volume
- 86
- Issue
- 1
- Pages
- 10-23
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2488700677
- Cited by
- 1,207
- References
- 14
- FWCI
- 27.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development. https://app.cochat.ai/papers/10.1097/00000542-199701000-00004
- The paper
- Minto, C. F., Schnider, T. W., Egan, T. D., Youngs, E., Lemmens, H. J. M., Gambus, P. L., Billard, V., Hoke, J. F., Moore, K. H. P., Hermann, D. J., Muir, K. T., Mandema, J. W., & Shafer, S. L. (1997). Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil: I. Model Development. Anesthesiology. https://doi.org/10.1097/00000542-199701000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.